However, overexpression of FGF4 is reported to be associated with aggravation of tumorigenesis and invasion in many cancers, such as hepatocellular carcinoma [158], lung adenocarcinoma [159], urinary bladder cancer [160], ovarian cancer [161], and breast cancer [162]. This evidence concerns the gene FGF4 and breast carcinoma.